Pfizer wins $10B bidding war for obesity drug developer Metsera in major pharmaceutical acquisition

Pfizer has won a $10 billion deal to acquire obesity drug developer Metsera, securing foothold in lucrative weight-loss ...
BioSpace

Pfizer’s Winning Bid for Metsera Concludes ‘Real Housewives of Biopharma’

“No need for a reunion show: This seasons Real Housewives of Biopharma comes to a close with Pfizer’s winning bid for Metsera ...

Metsera falls after accepting up to $10 billion sweetened buyout offer from Pfizer

(Reuters) -Shares of Metsera fell over 15% in premarket trading on Monday, after the weight-loss drug developer accepted a ...
Fierce Biotech

Pfizer beats out Novo with $10B agreement to buy Metsera

After a chaotic and fierce bidding clash that only burst out into public view a little more than a week ago, Pfizer has ...

Why a Strong Quarter Wasn't Enough to Send Shares of Pfizer Soaring

Pfizer not only beat expectations last quarter, but also boosted its guidance.

Metsera falls after accepting up to $10 billion offer from Pfizer

By Mariam Sunny (Reuters) -Shares of Metsera fell over 15% in early trading on Monday, after the weight-loss drug developer ...

Pfizer shows hardball mettle needed to win in 2025 M&A

Pharma giant had to pay a blockbuster price to buy Metsera after the biotech prospect spurred an auction with Novo Nordisk ...
STAT

The $10 billion question: Will Pfizer hit it big with Metsera, or have regrets?

At a price of up to $10 billion, Pfizer has claimed victory in its bidding war against Novo Nordisk to acquire Metsera. It's ...